drugset / Trial / NCT00814658
The Use of Galantamine (Reminyl ER) in Patients With MIXed Dementia: Effects on Cognition and Quality of Life
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the combination of galantamine with nimodipine in patients with mixed dementia on cognition and quality of life.
Timeline
- Start
- 2008-06
- Primary completion
- 2009-10
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Galantamine | Small molecule | 24 mg | Oral |
| Subject | Nimodipine | Small molecule | 30 mg | Oral |